Immunic
IMUX
IMUX
75 hedge funds and large institutions have $78.5M invested in Immunic in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
29% more funds holding
Funds holding: 58 → 75 (+17)
0.77% more ownership
Funds ownership: 4.26% → 5.03% (+0.77%)
Holders
75
Holding in Top 10
–
Calls
$526K
Puts
$81K
Top Buyers
| 1 | +$4.03M | |
| 2 | +$2.39M | |
| 3 | +$2.19M | |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$2.1M |
| 5 |
Morgan Stanley
New York
|
+$1.07M |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$1.68M | |
| 3 | -$282K | |
| 4 |
Squarepoint
New York
|
-$188K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$174K |
